The Inter-University Centre for Biomedical Research at Mahatma Gandhi University has secured its first patent from the Government of India for a novel nanocarrier designed to deliver drugs directly to neuronal mitochondria.
The patent (No. 582721), granted on March 10, 2026, covers the invention titled “A Polyglycerol-Based Nanocarrier and a Process for Preparation Thereof.” The patent application (No. 202541053989) had been filed on June 4, 2025.
The technology introduces a specially designed polyglycerol-based nanocarrier capable of targeting mitochondria within neurons. Such targeted drug delivery is expected to enhance the effectiveness of treatments for neurodegenerative disorders such as Parkinson’s disease and Alzheimer’s disease. Since mitochondrial dysfunction is considered a key factor in these conditions, the innovation could enable therapies to act precisely at the affected cellular sites while minimising side effects.
The invention was developed by researchers Nishad Keethedeth, Dr Rajesh Anantha Shenoi, Dr Goutam Chandra and Prof Mohanakumar Kochupurackal. Researchers noted that the breakthrough bridges advanced nanomedicine research with potential clinical applications, opening new possibilities for the treatment of neurodegenerative diseases.
